[{"Assets_0_Q1_USD":951639000.0,"CommonStockSharesOutstanding_0_Q1_shares":40954615.0,"EarningsPerShareBasic_1_Q1_USD":0.26,"EarningsPerShareDiluted_1_Q1_USD":0.23,"NetIncomeLoss_1_Q1_USD":10485000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":49718426.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":40727755.0,"Ticker":"EBS","CIK":"1367644","name":"EMERGENT BIOSOLUTIONS INC.","OfficialName":"Emergent Biosolutions Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2077670312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20170505"}]